Colorado Springs, CONCT07654829Now EnrollingIRB Ready

Hereditary Angioedema Clinical Trial in Colorado Springs, CO

Access cutting-edge hereditary angioedema treatment through this phase 4 clinical trial at a research site in Colorado Springs. Study-provided care at no cost to qualified participants.

Sponsored by KalVista Pharmaceuticals, Ltd.

Quick Self-Assessment

See if you qualify for this Colorado Springs location

Preparing your pre-screening questions…

Expert Care in Colorado Springs

Access hereditary angioedema specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hereditary angioedema treatment provided free

Apply for This Colorado Springs Location

Check if you qualify for this hereditary angioedema clinical trial in Colorado Springs, CO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Colorado Springs

    Convenient for CO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Colorado Springs site if eligible
  4. 4Begin participation

About This Hereditary Angioedema Study in Colorado Springs

This is a Phase 4, prospective, open-label trial to evaluate the safety and effectiveness of sebetralstat when used for STP for a qualifying procedures in patients 12 years of age or older with hereditary angioedema (HAE).

Sponsor: KalVista Pharmaceuticals, Ltd.

Who Can Participate

Inclusion Criteria

Male or female patients ≥12 years of age at time of Screening
Confirmed diagnosis of HAE Type I or II based on patient report
Patient has a qualifying procedure that is scheduled or planned to be scheduled to occur within 8 weeks of Screening
Patient has access to a commercial available on-demand treatment for HAE
Female patients of childbearing potential, including post-menarchal adolescents, must meet contraception requirements per Section 11.3. (Note: male patients do not require contraception)
Patients must be able to swallow trial tablets whole
Patients, as assessed by the Investigator, must be able to appropriately receive and store IMP, and be able to read, understand, and complete the questionnaire
Investigator believes that the patient is willing and able to adhere to all protocol requirements through the duration of the trial
Patient provides informed consent or assent (when applicable). A parent or legally authorized representative (LAR) must also provide signed informed consent when required

Exclusion Criteria

A clinically significant history of poor response to bradykinin receptor 2 blocker, C1-INH therapy, or plasma kallikrein inhibitor therapy for the management of HAE, in the opinion of the Investigator
Use of angiotensin-converting enzyme (ACE) inhibitors within 7 days prior to the Screening Visit
Any estrogen-containing medications with systemic absorption (such as oral contraceptives including ethinylestradiol or hormonal replacement therapy) within 7 days prior to the Screening Visit
Patients who are taking strong cytochrome P450 (CYP)3A4 inhibitors or inducers or moderate CYP3A4 inducers within 2 weeks of the procedure
Any clinically significant comorbidity or systemic dysfunction, which in the opinion of the Investigator, would jeopardize the safety of the patient by participating in the trial
History of substance abuse or dependence that would interfere with the completion of the trial, as determined by the Investigator
Known hypersensitivity to sebetralstat or to any of the excipients
Participation in any gene therapy treatment or trial for HAE
Any pregnant or breastfeeding patient

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Colorado Springs?

Yes, this clinical trial (NCT07654829) has an active research site in Colorado Springs, CO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hereditary Angioedema Treatment Options in Colorado Springs, CO

If you're searching for hereditary angioedema treatment options in Colorado Springs, CO, this clinical trial (NCT07654829) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Colorado Springs research site is actively enrolling participants for this phase 4 clinical trial. You'll receive care from experienced hereditary angioedema specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hereditary angioedema clinical trials near you to find additional studies recruiting in your area.

More Erectile Dysfunction Trials in Colorado Springs, CO

See all erectile dysfunction clinical trials recruiting in Colorado Springs — not just this study.

Browse Erectile Dysfunction Trials in Colorado Springs →

Browse More Trials by Condition

Erectile Dysfunction TrialsHereditary Angioedema TrialsUrticaria TrialsAll Conditions →

Ready to Join in Colorado Springs?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Colorado Springs, CO